These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16044033)

  • 1. Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat.
    Hale SL; Sesti C; Kloner RA
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):211-5. PubMed ID: 16044033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
    Xu K; George I; Klotz S; Hay I; Xydas S; Zhang G; Cerami A; Wang J
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):506-12. PubMed ID: 20881614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
    Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
    Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
    JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study.
    Taniguchi N; Nakamura T; Sawada T; Matsubara K; Furukawa K; Hadase M; Nakahara Y; Nakamura T; Matsubara H
    Circ J; 2010 Nov; 74(11):2365-71. PubMed ID: 20834185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model.
    Ben-Dor I; Hardy B; Fuchs S; Kaganovsky E; Kadmon E; Sagie A; Coleman R; Mansur M; Politi B; Fraser A; Harell D; Okon E; Battler A; Haim M
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):339-46. PubMed ID: 17912622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.
    Ludman AJ; Yellon DM; Hasleton J; Ariti C; Babu GG; Boston-Griffiths E; Venugopal V; Walker M; Holdright D; Swanton H; Crake T; Brull D; Moon JC; Puranik R; Muthurangu V; Taylor A; Hausenloy DJ
    Heart; 2011 Oct; 97(19):1560-5. PubMed ID: 21900585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early erythropoietin therapy attenuates remodeling and preserves function of left ventricle in porcine myocardial infarction.
    Chua S; Leu S; Lin YC; Sheu JJ; Sun CK; Chung SY; Chai HT; Lee FY; Kao YH; Wu CJ; Chang LT; Ko SF; Yip HK
    J Investig Med; 2011 Mar; 59(3):574-86. PubMed ID: 21200333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits.
    Yamada Y; Kobayashi H; Iwasa M; Sumi S; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Kiso M; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1124-33. PubMed ID: 23417861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endurance training early or late after coronary artery occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction.
    Gaudron P; Hu K; Schamberger R; Budin M; Walter B; Ertl G
    Circulation; 1994 Jan; 89(1):402-12. PubMed ID: 8281676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
    Hirata A; Minamino T; Asanuma H; Fujita M; Wakeno M; Myoishi M; Tsukamoto O; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Shiraga M; Kitakaze M; Hori M
    J Am Coll Cardiol; 2006 Jul; 48(1):176-84. PubMed ID: 16814664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Surface Cooling by ThermoSuit System Dramatically Reduces Scar Size, Prevents Post-Infarction Adverse Left Ventricular Remodeling, and Improves Cardiac Function in Rats.
    Dai W; Herring MJ; Hale SL; Kloner RA
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26116692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
    Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
    Ahmet I; Tae HJ; Brines M; Cerami A; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2013 Jun; 345(3):446-56. PubMed ID: 23584743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
    Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
    Villarreal FJ; Griffin M; Omens J; Dillmann W; Nguyen J; Covell J
    Circulation; 2003 Sep; 108(12):1487-92. PubMed ID: 12952845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
    Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
    Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.
    Melloni C; Rao SV; Povsic TJ; Melton L; Kim RJ; Kilaru R; Patel MR; Talan M; Ferrucci L; Longo DL; Lakatta EG; Najjar SS; Harrington RA
    Am Heart J; 2010 Nov; 160(5):795-803.e2. PubMed ID: 21095264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.